Now in its 7th year, the World Stem Cells & Regenerative Medicine Congress is expertly designed to assist industry overcome the challenges faced during cell therapy development and harness the use of stem cells in drug discovery. This senior level congress promises to deliver real and novel solutions to take back to your organisation and provide a steadfast foundation for meeting your business objectives. As an interactive forum to engage and network with the contacts you need to grow, the World Stem Cells & Regenerative Medicine Congress 2012 is the hotbed for all stakeholders of the industry as stem cell-based and regenerative medicine pioneers to transform the future of healthcare.
Come to World Stem Cells & Regenerative Medicine Congress and learn how to:
• Overcome regulatory hurdles
• Identify successful stem cell therapy
• Obtain reimbursement
• Understand Stem Cells in a new age of Drug Discovery
• Explore commercial potential in academic research
• Use stem cell technology for drug target discovery and toxicity testing
• Secure investment for stem cell product development
Key speakers include:
• Gil van Bokkelen, Chairman & CEO, Athersys
• Michael May, CEO, Centre for Commercialisation of Regenerative Medicine (CCRM)
• Zahid Latif, Lead Technologist, TSB
• Lee Rubin, Principle Investigator, Harvard Stem Cell Institute
• Chris Mason, Director Regenerative Medicine Bioprocessing Unit, UCL
• Michael Werner, Executive Director, ARM